Clinical trial
Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer
NCT00217815 · NeuTec Pharma, Industry · Completed
Key facts
| NCT number | NCT00217815 |
|---|---|
| Title | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer |
| Official title | A Phase Ib, Pharmacokinetic, Multiple Center, Open Label Study Evaluating the Safety and Efficacy of Mycograb Administered IV in Combination With Docetaxel in Metastatic or Recurrent Breast Cancer Patients |
| Lead sponsor | NeuTec Pharma, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cancer of the Breast |
| Intervention type | Drug |
| Interventions | Mycograb, Docetaxel |
| Enrollment | 20 |
| Start date | Sep 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 15, 2008 |
| Countries | Poland, Serbia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: